A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0123-0338 in Healthy Subjects and in Subjects With Type 1 Diabetes Mellitus
Clinical trial NCT02220296 · COMPLETED
Trial details
- NCT number
- NCT02220296
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-20
- Primary completion
- 2015-03-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.